SI0901470T1 - Indole derivatives useful as endothelin receptor antagonists - Google Patents

Indole derivatives useful as endothelin receptor antagonists

Info

Publication number
SI0901470T1
SI0901470T1 SI9730646T SI9730646T SI0901470T1 SI 0901470 T1 SI0901470 T1 SI 0901470T1 SI 9730646 T SI9730646 T SI 9730646T SI 9730646 T SI9730646 T SI 9730646T SI 0901470 T1 SI0901470 T1 SI 0901470T1
Authority
SI
Slovenia
Prior art keywords
receptor antagonists
indole derivatives
endothelin receptor
derivatives useful
useful
Prior art date
Application number
SI9730646T
Other languages
English (en)
Slovenian (sl)
Inventor
David James Rawson
Kevin Neil Dack
Roger Peter Dickinson
Kim James
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of SI0901470T1 publication Critical patent/SI0901470T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
SI9730646T 1996-05-09 1997-04-11 Indole derivatives useful as endothelin receptor antagonists SI0901470T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9609641.7A GB9609641D0 (en) 1996-05-09 1996-05-09 Compounds useful in therapy
PCT/EP1997/001882 WO1997043260A1 (en) 1996-05-09 1997-04-11 Indole derivatives useful as endothelin receptor antagonists
EP97920690A EP0901470B1 (en) 1996-05-09 1997-04-11 Indole derivatives useful as endothelin receptor antagonists

Publications (1)

Publication Number Publication Date
SI0901470T1 true SI0901470T1 (en) 2004-08-31

Family

ID=10793387

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730646T SI0901470T1 (en) 1996-05-09 1997-04-11 Indole derivatives useful as endothelin receptor antagonists

Country Status (43)

Country Link
US (4) US6017945A (tr)
EP (1) EP0901470B1 (tr)
JP (1) JP3245179B2 (tr)
KR (1) KR100331217B1 (tr)
CN (1) CN1124262C (tr)
AP (1) AP830A (tr)
AR (1) AR007030A1 (tr)
AT (1) ATE263151T1 (tr)
AU (1) AU717849B2 (tr)
BG (1) BG102873A (tr)
BR (1) BR9709072A (tr)
CA (1) CA2253876A1 (tr)
CO (1) CO4650036A1 (tr)
CZ (1) CZ292928B6 (tr)
DE (1) DE69728392T2 (tr)
DK (1) DK0901470T3 (tr)
DZ (1) DZ2227A1 (tr)
EA (1) EA001471B1 (tr)
ES (1) ES2218675T3 (tr)
GB (1) GB9609641D0 (tr)
HK (1) HK1019149A1 (tr)
HN (1) HN1997000058A (tr)
HR (1) HRP970249B1 (tr)
HU (1) HUP9901245A3 (tr)
ID (1) ID16878A (tr)
IL (1) IL125903A0 (tr)
IS (1) IS1856B (tr)
MA (1) MA26428A1 (tr)
NO (1) NO312547B1 (tr)
NZ (1) NZ332640A (tr)
OA (1) OA10896A (tr)
PE (1) PE65098A1 (tr)
PL (1) PL329725A1 (tr)
PT (1) PT901470E (tr)
SI (1) SI0901470T1 (tr)
SK (1) SK150398A3 (tr)
TN (1) TNSN97078A1 (tr)
TR (1) TR199802269T2 (tr)
TW (1) TW491838B (tr)
UA (1) UA50767C2 (tr)
UY (1) UY24546A1 (tr)
WO (1) WO1997043260A1 (tr)
ZA (1) ZA973963B (tr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722287D0 (en) * 1997-10-22 1997-12-17 Pfizer Ltd Compounds useful in therapy
RU2262935C2 (ru) * 1999-02-10 2005-10-27 Астразенека Аб Производные хиназолина в качестве ингибиторов ангиогенеза
US20050203166A1 (en) * 2000-06-30 2005-09-15 Cancer Research Technology Limited Indole-3-acetic acid derivatives
GB0016162D0 (en) * 2000-06-30 2000-08-23 Cancer Res Campaign Tech Indole-3-acetic acid derivatives
TWI224101B (en) 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
DK1397130T3 (da) 2001-06-20 2007-11-12 Wyeth Corp Substituerede indolsyrederivater som inhibitorer af plasminogenaktivatorinhibitor-1 (PAI-1)
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
JP2006510672A (ja) 2002-12-10 2006-03-30 ワイス プラスミノーゲン活性化因子の阻害因子−１（ｐａｉ−１）の阻害剤としての置換インドールオキソ−アセチルアミノ酢酸誘導体
AU2003297727A1 (en) 2002-12-10 2004-06-30 Wyeth Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
MXPA05006288A (es) 2002-12-10 2005-08-19 Wyeth Corp Derivados del acido 3-carbonil-1h-indol-1-ilacetico sustituidos como inhibidores del inhibidor del activador de plasminogeno 1 (pai-1).
ATE411288T1 (de) 2002-12-10 2008-10-15 Wyeth Corp Aryl-, aryloxy- und alkyloxysubstituierte 1h- indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
UA80453C2 (en) 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
JP2007500253A (ja) * 2003-01-22 2007-01-11 イーライ リリー アンド カンパニー ステロイドホルモン核内受容体のインドール誘導体モジュレーター
US7351726B2 (en) 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
US7442805B2 (en) 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
US7420083B2 (en) 2003-09-25 2008-09-02 Wyeth Substituted aryloximes
US7332521B2 (en) 2003-09-25 2008-02-19 Wyeth Substituted indoles
US7582773B2 (en) 2003-09-25 2009-09-01 Wyeth Substituted phenyl indoles
US7163954B2 (en) 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
US7268159B2 (en) 2003-09-25 2007-09-11 Wyeth Substituted indoles
US7411083B2 (en) 2003-09-25 2008-08-12 Wyeth Substituted acetic acid derivatives
US7141592B2 (en) 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
US7342039B2 (en) 2003-09-25 2008-03-11 Wyeth Substituted indole oximes
US7446201B2 (en) 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7265148B2 (en) 2003-09-25 2007-09-04 Wyeth Substituted pyrrole-indoles
JP2005109006A (ja) * 2003-09-29 2005-04-21 Tdk Corp 高電圧貫通型コンデンサ及びマグネトロン
HN2004000536A (es) 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
MX2007002178A (es) 2004-08-23 2007-04-02 Wyeth Corp Acidos de oxazolo-naftilo como moduladores del inhibidor del activador de plasminogeno tipo 1 (pai-1) util en el tratamiento de trombosis y enfermedades cardiovasculares.
JP2009504762A (ja) 2005-08-17 2009-02-05 ワイス 置換インドール類およびそれらの使用方法
WO2007119214A2 (en) * 2006-04-13 2007-10-25 Actelion Pharmaceuticals Ltd Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
DE102008030207A1 (de) 2008-06-25 2009-12-31 Bayer Schering Pharma Aktiengesellschaft Substituierte 7-Sulfanylmethyl-, 7-Sulfinylmethyl- und 7-Sulfonylmethyl-Indole und ihre Verwendung
DE102008030206A1 (de) 2008-06-25 2009-12-31 Bayer Schering Pharma Aktiengesellschaft 3-Cyanoalky- und 3-Hydroxyalkyl-Indole und ihre Verwendung
CN106674065A (zh) * 2016-12-07 2017-05-17 贵州大学 一种5‑卤代‑2‑烷氧基‑4‑甲苯磺酰氯制备方法
GB201817038D0 (en) * 2018-10-19 2018-12-05 Inflazome Ltd Novel processes
WO2020176599A1 (en) 2019-02-27 2020-09-03 The Regents Of The University Of California Azepino-indoles and other heterocycles for treating brain disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637355A (tr) * 1962-09-14
DE1950346B2 (de) * 1968-10-08 1973-06-28 Sumitomo Chemical Co 2-indolylessigsaeureverbindungen und diese verbindungen enthaltende arzneipraeparate
US4397079A (en) * 1981-03-30 1983-08-09 International Business Machines Corp. Process for improving the yield of integrated devices including Schottky barrier diodes
US5245046A (en) * 1988-11-14 1993-09-14 The Upjohn Company α-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
JP3334087B2 (ja) * 1990-09-10 2002-10-15 アヴェンティス ファーマシューティカルズ インコーポレイテッド 選択的ロイコトリエンｂ▲４▼拮抗剤活性を示す置換された二環式アリール化合物
ZA939516B (en) * 1992-12-22 1994-06-06 Smithkline Beecham Corp Endothelin receptor antagonists
DE69422742T2 (de) * 1993-03-19 2000-08-17 Merck & Co., Inc. Phenoxyphenylessigsäurederivate
GB9317096D0 (en) * 1993-08-17 1993-09-29 Pfizer Ltd Indoles

Also Published As

Publication number Publication date
US6017945A (en) 2000-01-25
GB9609641D0 (en) 1996-07-10
NO985225D0 (no) 1998-11-09
US20010014677A1 (en) 2001-08-16
BG102873A (en) 1999-11-30
MA26428A1 (fr) 2004-12-20
HRP970249B1 (en) 2003-06-30
ZA973963B (en) 1998-11-09
AP830A (en) 2000-05-03
JPH11508285A (ja) 1999-07-21
US6384070B2 (en) 2002-05-07
KR100331217B1 (ko) 2002-05-09
TNSN97078A1 (fr) 2005-03-15
NO312547B1 (no) 2002-05-27
CO4650036A1 (es) 1998-09-03
CZ358298A3 (cs) 1999-08-11
UA50767C2 (uk) 2002-11-15
IS1856B (is) 2003-02-21
EA001471B1 (ru) 2001-04-23
DE69728392D1 (de) 2004-05-06
IL125903A0 (en) 1999-04-11
DE69728392T2 (de) 2005-01-13
CN1124262C (zh) 2003-10-15
PE65098A1 (es) 1998-10-29
HUP9901245A3 (en) 2002-01-28
BR9709072A (pt) 1999-08-03
DZ2227A1 (fr) 2002-12-25
AU2697897A (en) 1997-12-05
US6136843A (en) 2000-10-24
KR20000010879A (ko) 2000-02-25
TW491838B (en) 2002-06-21
PL329725A1 (en) 1999-04-12
HUP9901245A2 (hu) 1999-08-30
OA10896A (en) 2001-10-11
CN1216531A (zh) 1999-05-12
US6306852B1 (en) 2001-10-23
CZ292928B6 (cs) 2004-01-14
ES2218675T3 (es) 2004-11-16
WO1997043260A1 (en) 1997-11-20
DK0901470T3 (da) 2004-07-12
NO985225L (no) 1998-11-09
CA2253876A1 (en) 1997-11-20
TR199802269T2 (tr) 2001-12-21
EP0901470A1 (en) 1999-03-17
JP3245179B2 (ja) 2002-01-07
EA199800908A1 (ru) 1999-06-24
AP9700982A0 (en) 1997-07-31
EP0901470B1 (en) 2004-03-31
HN1997000058A (es) 1997-06-26
HK1019149A1 (en) 2000-01-14
ATE263151T1 (de) 2004-04-15
SK150398A3 (en) 1999-03-12
AR007030A1 (es) 1999-10-13
NZ332640A (en) 2001-03-30
IS4838A (is) 1998-08-28
PT901470E (pt) 2004-07-30
HRP970249A2 (en) 1998-06-30
AU717849B2 (en) 2000-04-06
ID16878A (id) 1997-11-20
UY24546A1 (es) 2000-09-29

Similar Documents

Publication Publication Date Title
HK1019149A1 (en) Indole derivatives useful as endothelin receptor antagonists
AU4746297A (en) Vitronectin receptor antagonists
HU9601529D0 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
GB9718913D0 (en) Substituted oxindole derivatives
GR3035075T3 (en) Indole derivatives as 5-ht receptor antagonist
EP0912175A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
IL123581A0 (en) Pyrimidine derivatives as 5HT2c- receptor antagonists
EP0885205A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
EP0885213A4 (en) FIBRINOGEN RECEPTOR ANTAGONISTS
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
IL127304A0 (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
AU1296899A (en) Phenyl-alkyl-imidazoles as h3 receptor antagonists
HUP9903439A3 (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
AU8871898A (en) Phenylindole derivatives as 5-ht2a receptor antagonists
AU3611099A (en) Oxindole derivatives used as neurokinin receptor antagonists
AU4980999A (en) A3 adenosine receptor antagonists
AU1150999A (en) Indole derivative useful as endothelin receptor antagonist
AU6826498A (en) Endotholin receptor antagonists
AU2943899A (en) Indole derivatives as 5-ht2a receptor antagonists
SI0912556T1 (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
EP0957908A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
GB9811283D0 (en) Vironectin receptor antagonists
IL108842A0 (en) Benzylimidazopyridine derivatives as angiotensin II receptor antagonists
AU2230697A (en) Quinoxaline derivatives as glutamate receptor antagonists
GB9603371D0 (en) Fibrinogen receptor antagonists